E88.02 — Plasminogen deficiency
Is E88.02 billable?
Yes — E88.02 is billable for FY2027. E88.02 is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. E88.02 may be submitted for encounters from October 1, 2026 through September 30, 2027.
E88.02 at a glance
| Code | E88.02 |
|---|---|
| Description | Plasminogen deficiency |
| Billable | Yes |
| Code set | ICD-10-CM FY2027 |
| Valid for encounters | October 1, 2026 – September 30, 2027 |
Which MS-DRGs does E88.02 group to?
E88.02 sits in MDC 17 and helps define the logic of 3 MS-DRGs (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.
- 826Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures with MCCsurgical
- 827Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures with CCsurgical
- 828Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures without CC/MCCsurgical
As a secondary diagnosis, E88.02 is a complication or comorbidity (CC), which can move a stay into a higher-paying DRG.
How is E88.02 listed in the Alphabetic Index?
These are the routes through the Alphabetic Index that lead to E88.02. They show the wording a clinician may have documented, which often differs from the Tabular description.
- Dysplasminogenemia
- Hypoplasminogenemia
- Deficiency, deficient › plasminogen
Use additional code
Report an additional code alongside E88.02 to fully describe the condition. E88.02 is sequenced first.
Code also
Two codes may be needed to describe the condition fully. Whether E88.02 is sequenced first depends on the reason for the encounter.
- , if applicable, ligneous conjunctivitis (H10.51-)
Inclusion terms
Alternative wording in documentation that is classified to E88.02.
- Dysplasminogenemia
- Hypoplasminogenemia
- Type 1 plasminogen deficiency
- Type 2 plasminogen deficiency
Excludes1 — never code together — inherited from Chapter 4
The conditions below can never be reported together with E88.02 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.
- transitory endocrine and metabolic disorders specific to newborn (P70-P74)
Excludes1 — never code together — inherited from E70-E88
The conditions below can never be reported together with E88.02 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.
Excludes1 — never code together — inherited from E88
The conditions below can never be reported together with E88.02 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.
- histiocytosis X (chronic) (C96.6)
Excludes1 — never code together — inherited from E88.0
The conditions below can never be reported together with E88.02 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.
Use additional code — inherited from E88
Report an additional code alongside E88.02 to fully describe the condition. E88.02 is sequenced first.
- codes for associated conditions
Excludes2 — not included here — inherited from E70-E88
The conditions below are not part of E88.02, but a patient may have both at the same time. When documentation supports it, E88.02 and the excluded code may both be reported.
- Ehlers-Danlos syndromes (Q79.6-)
Excludes2 — not included here — inherited from E88.0
The conditions below are not part of E88.02, but a patient may have both at the same time. When documentation supports it, E88.02 and the excluded code may both be reported.
- disorder of lipoprotein metabolism (E78.-)
How long has E88.02 existed?
E88.02 first appears in FY2019.
Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.